The pharmacy at the White House repeatedly gave controlled drugs to ineligible staffers, according to an inspector general.
“All phases of the White House Medical Unit’s pharmacy operations had severe and systemic problems due to the unit’s reliance on ineffective internal controls to ensure compliance with pharmacy safety standards,” the U.S. Department of Defense’s Office of Inspector General said in a report this month detailing its investigation into allegations the White House clinic was engaging in “improper medical practices.”
